StockCall Scrutinizes Pfizer, Merck & Co., Johnson & Johnson, and AbbVie

   StockCall Scrutinizes Pfizer, Merck & Co., Johnson & Johnson, and AbbVie

PR Newswire

LONDON, April 10, 2013

LONDON, April 10, 2013 /PRNewswire/ --

The Dow Jones Index closed at an all time high at 14,673.46, up 0.41 percent
while NASDAQ was up 0.48 percent to end yesterday's session at 3,237.86.
Similarly, S&P also finished Tuesday's trading session on a positive note at
1,568.61, up 0.35 percent. The markets showed across the board improvement and
a bullish trend. Our research team took a look at the Healthcare sector,
focusing on the major drug makers industry which include including companies
like Pfizer Inc. (NYSE: PFE), Merck & Co. Inc. (NYSE: MRK), Johnson & Johnson
(NYSE: JNJ) and AbbVie Inc. (NYSE: ABBV). StockCall reviewed the Drug
Manufacturers - Major industry and chose PFE, MRK, JNJ, and ABBV for its
technical coverage. These free reports can be seen for free at

Pfizer Inc. is trading below its long-term moving average price, indicating a
neutral trend. It also closed its latest trading session at $29.11, down 0.17
percent. The stock made its downward movement with below average volume of
27.53 million shares. Pfizer Inc. trades at Price/Earnings ratio of 23.10,
in-line with industry average, making the stock a fairly priced proposition.
However, the stock provided good return to its holders as it appreciated 16.95
percent this year. Pfizer's stock also gained 30.3 percent in the past 52
weeks, and it oscillated between $21.40 and $29.44 during this time period.
Download the free research on PFE by signing up now at

Merck & Co. Inc. is currently trading in overbought territory with its
Relative Strength Index at 70.18. Consequently, the stock may see some
pullback in the coming sessions. It closed its Tuesday's session at $45.51, up
0.07 percent. The stock is currently in a bullish mode and may touch $45.67
level in the coming days. Upon breaching this level, the stock's next
resistance price is at $47.96. the drug maker's stock has low volatility with
its beta at 0.58. So far in 2013, the stock appreciated 11.98 percent. Its 52
weeks gain stands at 17.05 percent. The stock has traded in the range of
$37.02 and $48 during the said time period. Register for today's free analysis
on MRK at

Johnson & Johnson extended its 52 weeks gain by closing 0.51 percent higher.
The stock ended Tuesday's session at $81.52, while its highest price point for
the session stood at $81.75. It traded 9.08 million shares, down from its
average daily volume of 9.98 million. Johnson & Johnson traded in the range of
$61.71 and $82.95 in the past 52 weeks, and currently it is trading near its
high price point. The company commands market capitalization of $228.01
billion and it reported its latest EPS at $3.86. Johnson & Johnson's stock
gained more than 24 percent in the past 52 weeks. Free report on JNJ can be
accessed by registering at

AbbVie Inc. traded up with above average volume to end its latest session at
$42.55. The stock ended 1.87 percent higher than its previous close. Its
volume for the day stood at 8.67 million shares. The stock is currently
trading marginally lower than its 20-day SMA of $42.58 and its 50-day SMA of
$42.77. Its first resistance level is at $42.87 while it may tumble down to
$42.33 before receiving any support. AbbVie's stock is up 23.26 percent on a
YTD basis, while offering 3.76 percent dividend yield. Register with StockCall
and download the research on ABBV for free at

About is a financial website where investors can have easy, precise
and comprehensive research and opinions on stocks making the headlines. Sign
up today to talk to our financial analyst at 


Contact: Contact Person: William T. Knight, Email:, Contact
Number: +1(646)396-9857 (9:00 am EST - 01:30 pm EST)
Press spacebar to pause and continue. Press esc to stop.